Cart (0 Items)
Your cart is currently empty.
View Products
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG4, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Pepinemab Biosimilar - Anti-SEMA4D mAb - Research Grade |
|---|---|
| Source | CAS 2097151-87-4 |
| Species | Humanized |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery lead time in business days | 3-5 days if in stock; 3-5 weeks if production needed |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Pepinemab ,VX-15,VX15/2503,SEMA4D,anti-SEMA4D |
| Reference | PX-TA1382 |
| Note | For research use only. Not suitable for human use. |
| Isotype | IgG4-kappa |
| Clonality | Monoclonal Antibody |
Pepinemab is investigated for the treatment of Resectable Stage IIIB-D Melanoma with or without Ipilimumab and/or Nivolumab.
Pepinemab Biosimilar - Anti-SEMA4D mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Related products
Send us a message from the form below
Reviews
There are no reviews yet.